Available Technologies

Find technologies available for licensing from all ten University of California (UC) campuses.

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Neuronal Injury Targeted Engineered Placental Mesenchymal Stem Cell Derived Extracellular Vesicles

Researchers at the University of California, Davis have developed an extracellular vesicle composition conjugated with targeting peptides to localize treatment to central nervous system injury sites, enhancing neural tissue preservation and recovery.

Electronic Health Record Agent Swarm

Researchers at UC Irvine has developed an AI-powered hospital analytics platform that helps healthcare leaders quickly find answers hidden within large collections of patient records. Instead of relying on traditional reports or manual chart reviews, users simply ask questions in everyday language. The platform automatically analyzes thousands of electronic health records, including clinical notes and reports that conventional analytics systems cannot easily interpret. By combining advanced artificial intelligence with hospital data, the system provides fast, data-driven insights that improve operational decision making, reduce administrative burden, and help hospitals identify opportunities to improve patient flow, resource utilization, safety monitoring, and overall efficiency.

Castable Nb-Mo-C Eutectic Superalloy for Ultrahigh Temperature Applications

Researchers at the University of California, Davis have developed nano-eutectic niobium-based superalloys designed for exceptional strength, ductility, and stability at ultrahigh temperatures up to 1500ºC.

Oscillator-Based Attention for Machine Learning Systems

A novel method for implementing AI attention mechanism using the natural synchronization of physical oscillators, enabling more energy-efficient computation.

Targeted Nucleic Acid Editing via Cas9-Deaminase Fusion Proteins

Traditional genome editing relying on double-stranded DNA breaks (DSBs) can cause unintended indels, translocation events, and cytotoxic responses in target cells. To overcome these limitations, a precise site-specific modification technology is required that operates without inducing double-stranded DNA cleavage. Developed by UC Berkeley researchers, this technology utilizes engineered fusion proteins comprising a Cas domain (such as a Cas9 nickase or dCas9) integrated with a nucleic acid-editing enzyme domain, such as a deaminase. The molecular mechanism leverages the RNA-guided targeted binding capability of Cas9 to localize the enzymatic editing domain to a specific genomic locus, facilitating direct nucleotide alterations (e.g., cytidine or adenosine conversions) without introducing double-stranded cuts. This system delivers high-precision target modification, significantly reduces off-target insertion/deletion mutations, and improves cell viability during genomic modifications compared to conventional double-strand cleavage mechanisms.

Holistic Design And Optimization Of Millimeter-Wave Transmitters With Load-Modulated Balanced Power Amplifiers

A novel mm-wave transmitter architecture that integrates load-modulated balanced power amplifiers (LMBPA) and double quadrature (DQ) up-conversion for enhanced efficiency, image suppression, and antenna resilience.

Low-Power Leaky-Wave Radar With Single-Chain Doa Detection At 50–60 Ghz

A compact, low-power frequency modulated continuous wave (FMCW) radar system enabling high-resolution direction-of-arrival (DoA) detection using a single leaky-wave antenna and transceiver chain

Improved Trap Geometry For Optimal Hydrodynamic Intra-Droplet Microvortices.

An advanced microfluidic platform that enables high-throughput 3D imaging of live, non-adherent single cells using droplet-based microvortex rotation.